ArticleFrontiers in immunology2026

Ofatumumab in refractory anti-muscle-specific tyrosine kinase antibody-positive myasthenia gravis: a case report of successful salvage therapy and mechanistic insights.

Yikai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.